Fig. 1 · Structure
Documents & Downloads
Oxolamine
Cough Suppressant
Oxolamine is an orally active cough suppressant that primarily targets antitussive pathways. It has demonstrated anti-inflammatory effects on the respiratory tract in animal models, specifically in guinea pigs. Additionally, Oxolamine can inhibit CYP2B1/2, influencing the pharmacokinetics of co-administered drugs such as Warfarin. This compound is valuable for research applications focusing on respiratory diseases and the modulation of cough reflex mechanisms.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 959-14-8 |
| Applications | Cough Suppressant |
| Formula | C14H19N3O |
| Molecular Weight | 245.32 |
| SMILES | CCN(CC)CCC1=NC(C2=CC=CC=C2)=NO1 |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.